North America's Investment Leadership: Driving R&D and Clinical Trial Volume The North American region, particularly the United States, holds the largest revenue share and continues to serve as the dominant global hub for the small interfering RNA (siRNA) field. This regional leadership is fundamentally rooted in the massive, sustained investment by the US government and venture capital in fundamental life science research, combined with the presence of a vast,...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai
English
French
Spanish
Portuguese
Italiano
Portuguese (Brazil)
china